Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Beyond Biotech - the podcast from Labiotech
De-risking neurology drug development with better mouse models
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Today we welcome Brandy Wilkinson, CEO of GemPharmatech, and Rikki Feng, the company’s Neuroscience Pipeline Leader.
Our discussion focuses on a persistent challenge in drug development: neurology’s stubbornly high clinical failure rates. GemPharmatech is tackling this head-on with proprietary models for Alzheimer’s, Parkinson’s, and blood-brain barrier transport that better mirror human disease biology.
We explore why mouse models matter more in neurology than in other fields, the design principles behind these next-generation tools, and how smarter preclinical partnerships can help therapeutic developers de-risk programs earlier.
- 00:00 Welcome Brandy Wilkinson and Rikki Feng
- 03:17 GemPharmatech's mission
- 06:26 Why mouse models matter in neurology
- 11:11 Common translation gaps in neurology
- 18:09 Designing proprietary neurological disease models
- 25:45 Building stronger CRO strategic partnerships
- 33:58 An optimistic future of neuroscience research
This episode was produced with the support of GemPharmatech. Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
To dive deeper into the topic: